AHA Feb. 29 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies, its latest in a string of lawsuits claiming the federal law that created the 340B program preempts the state law. 

AbbVie, “like their fellow drug company AstraZeneca and the trade association representing their confederates, want to have their cake and eat it too,” AHA wrote. “AbbVie recognizes, as it must, that the 340B statute is silent as to contract pharmacy arrangements. But without citing any evidence (textual or otherwise) that Congress affirmatively intended to prevent states from addressing that issue, AbbVie insists that Congress’s silence has broad preemptive effect. The Court should reject that argument, which, at risk of mixing confectionary metaphors, is nothing more than an attempt by multibillion-dollar pharmaceutical companies to tell struggling healthcare providers and their poorest patients to ‘let them eat cake.’”

The Louisiana Hospital Association, Rural Hospital Coalition and 340B Health joined AHA in the brief.

Related News Articles

Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get…
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state’s 340B contract pharmacy law…
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…